03/04/2026
Time to change more than the clock.
If medication delays, callbacks, or supply gaps are disrupting your surgical flow, it may be time to rethink your post-op approach.
As an FDA-registered 503B outsourcing facility, OSRX supports practices nationwide with customized compounded ophthalmic medications designed for predictability:
• Reliable stock and delivery in all 50 states
• Flexible fulfillment — bulk to facility or direct-to-patient
• Streamlined onboarding and prescribing
• Responsive, knowledgeable customer support
Trusted by more than 10,000 prescribers nationwide.
Make post-op care easy — for your practice and your patients.
👉 Request pricing information: https://bit.ly/4tYqGDv
Prednisolone + Moxifloxacin + Bromfenac and other OSRX compounded postop medications carry serious risks, including burning and stinging upon instillation, conjunctivitis, decreased visual acuity, dry eye and bitter taste in mouth. View potential adverse events and contraindications at: https://osrxpharmaceuticals.com/osrxapiaecontraindication. For professional use only. OSRX specializes in customizing compounded medications to meet patient needs. Compounded drugs are not FDAapproved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality.
**posted on behalf of OSRX